caveolin-1 scaffolding domain peptide CSP7

FTTFTVT

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Chronic Obstructive Pulmonary Disease (COPD) 11/01/2023 - "This is reversed by caveolin-1 scaffolding domain peptide (CSP7) in preclinical models, suggesting the therapeutic potential of CSP7 for treating CS-induced lung injury (CS-LI) and COPD." 11/01/2023 - "Furthermore, treatment of AECs, AT2 cells, or lung tissue slices from patients with COPD or mice with CS-LI with a seven amino acid caveolin-1 scaffolding domain peptide (CSP7) reduced mucus hypersecretion in AECs and improved AT2 cell viability. "
2.	Lung Injury 11/01/2023 - "This is reversed by caveolin-1 scaffolding domain peptide (CSP7) in preclinical models, suggesting the therapeutic potential of CSP7 for treating CS-induced lung injury (CS-LI) and COPD."

1.	Amino Acids